GALE Related FDA

Dec 7, 2012 07:12 AM Galena (GALE) Presents New Data on SN-33, NeuVax Phase 1/2

Dec 6, 2012 07:08 AM Galena Biopharma (GALE), Leica Biosystems Enter NeuVax Partnership

Dec 4, 2012 07:08 AM Galena Biopharma (GALE) Enters NeuVax Commercialization Agreement w/ Teva (TEVA)

Oct 26, 2012 07:09 AM Galena Biopharma (GALE) Presents Data from NeuVax Phase 1/2 in Breast Cancer

Aug 13, 2012 07:10 AM Galena Biopharma (GALE) Gets Japanese Patent for FBP Peptide Variants

Jun 5, 2012 07:08 AM Galena Biopharma (GALE) NeuVax Continues w/ Strong Safety Profile

Jun 4, 2012 07:07 AM Galena Biopharma (GALE) Updates from NeuVax Phase 1/2 Following Booster Inoculations; Will Present at ASCO

May 1, 2012 07:06 AM Galena Biopharma (GALE) Gets U.S. Patent Allowance for FBP Peptide Variants

Feb 14, 2012 07:06 AM Galena Biopharma (GALE) Initiates E39 Phase 1/2 in Two Gynecological Cancers

Jan 20, 2012 07:06 AM Galena Biopharma (GALE) Initiates NeuVax Phase 3

Jan 5, 2012 07:14 AM Galena Biopharma Announces IND for Phase 2 Trial for NeuVax Combined With Herceptin

Dec 9, 2011 07:06 AM Galena Biopharma (GALE) Updates on NeuVax w/ Herceptin Phase 2 Design

Dec 7, 2011 07:06 AM Galena (GALE) Reports Statistically Significant Data for NeuVax from Phase 2